Top Markets
#1 Official Trump Official Trump +43.09%
#2 Mubarak Mubarak +39.27%
#3 Melania Meme Melania Meme +38.90%
#4 The Bitcoin Bull The Bitcoin Bull +26.19%
#5 Movement Movement +20.30%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +19.82%
#7 EXOD EXOD +18.93%
#8 Dash Dash +16.89%
#9 Full Moon Full Moon +16.76%
#10 Verge Verge +16.10%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Immuno-Biological Laboratories Co., Ltd. Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd.

4570
Rank in Stocks #24051
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to... Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma or serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.
Share Price
$7.05
Last synced: 2026-08-21
Market Cap
$65.63M
Change (1 day)
-1.64%
Change (1 year)
117.11%
Country
JP
Trade Immuno-Biological Laboratories Co., Ltd. (4570)

Category

Healthcare
Revenue for Immuno-Biological Laboratories Co., Ltd. (4570)
Revenue in Aug 2026 TTM: 0
According to Immuno-Biological Laboratories Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immuno-Biological Laboratories Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH